|
|
| Line 1: |
Line 1: |
| | + | |
| | ==Preliminary structural investigations of a malarial protein secretion system.== | | ==Preliminary structural investigations of a malarial protein secretion system.== |
| - | <StructureSection load='4iod' size='340' side='right' caption='[[4iod]], [[Resolution|resolution]] 1.80Å' scene=''> | + | <StructureSection load='4iod' size='340' side='right'caption='[[4iod]], [[Resolution|resolution]] 1.80Å' scene=''> |
| | == Structural highlights == | | == Structural highlights == |
| - | <table><tr><td colspan='2'>[[4iod]] is a 3 chain structure with sequence from [http://en.wikipedia.org/wiki/Plaf7 Plaf7]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4IOD OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4IOD FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[4iod]] is a 3 chain structure with sequence from [https://en.wikipedia.org/wiki/Plasmodium_falciparum_3D7 Plasmodium falciparum 3D7]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4IOD OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=4IOD FirstGlance]. <br> |
| - | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=SO4:SULFATE+ION'>SO4</scene></td></tr> |
| - | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">PF11_0175, PF3D7_1116800 ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=36329 PLAF7])</td></tr>
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=4iod FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4iod OCA], [https://pdbe.org/4iod PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=4iod RCSB], [https://www.ebi.ac.uk/pdbsum/4iod PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=4iod ProSAT]</span></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=4iod FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=4iod OCA], [http://pdbe.org/4iod PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=4iod RCSB], [http://www.ebi.ac.uk/pdbsum/4iod PDBsum]</span></td></tr> | + | |
| | </table> | | </table> |
| | + | == Function == |
| | + | [https://www.uniprot.org/uniprot/Q8IIJ8_PLAF7 Q8IIJ8_PLAF7] |
| | <div style="background-color:#fffaf0;"> | | <div style="background-color:#fffaf0;"> |
| | == Publication Abstract from PubMed == | | == Publication Abstract from PubMed == |
| Line 18: |
Line 20: |
| | | | |
| | ==See Also== | | ==See Also== |
| - | *[[Heat Shock Proteins|Heat Shock Proteins]] | + | *[[Heat Shock Protein structures|Heat Shock Protein structures]] |
| | == References == | | == References == |
| | <references/> | | <references/> |
| | __TOC__ | | __TOC__ |
| | </StructureSection> | | </StructureSection> |
| - | [[Category: Plaf7]] | + | [[Category: Large Structures]] |
| - | [[Category: Egea, P F]] | + | [[Category: Plasmodium falciparum 3D7]] |
| - | [[Category: Aaa+ atpase clpb chaperone]] | + | [[Category: Egea PF]] |
| - | [[Category: Chaperone]]
| + | |
| - | [[Category: Malaria]]
| + | |
| - | [[Category: N-terminal cargo-binding domain]]
| + | |
| - | [[Category: Parasitophorous vacuole]]
| + | |
| - | [[Category: Protein translocation and unfolding]]
| + | |
| Structural highlights
Function
Q8IIJ8_PLAF7
Publication Abstract from PubMed
Caseinolytic chaperones and proteases (Clp) belong to the AAA+ protein superfamily and are part of the protein quality control machinery in cells. The eukaryotic parasite Plasmodium falciparum, the causative agent of malaria, has evolved an elaborate network of Clp proteins including two distinct ClpB ATPases. ClpB1 and ClpB2 are involved in different aspects of parasitic proteostasis. ClpB1 is present in the apicoplast, a parasite-specific and plastid-like organelle hosting various metabolic pathways necessary for parasite growth. ClpB2 localizes to the parasitophorous vacuole membrane where it drives protein export as core subunit of a parasite-derived protein secretion complex, the Plasmodium Translocon of Exported proteins (PTEX); this process is central to parasite virulence and survival in the human host. The functional associations of these two chaperones with parasite-specific metabolism and protein secretion make them prime drug targets. ClpB proteins function as unfoldases and disaggregases and share a common architecture consisting of four domains-a variable N-terminal domain that binds different protein substrates, followed by two highly conserved catalytic ATPase domains, and a C-terminal domain. Here, we report and compare the first crystal structures of the N terminal domains of ClpB1 and ClpB2 from Plasmodium and analyze their molecular surfaces. Solution scattering analysis of the N domain of ClpB2 shows that the average solution conformation is similar to the crystalline structure. These structures represent the first step towards the characterization of these two malarial chaperones and the reconstitution of the entire PTEX to aid structure-based design of novel anti-malarial drugs.
Structural mapping of the ClpB ATPases of Plasmodium falciparum: Targeting protein folding and secretion for antimalarial drug design.,AhYoung AP, Koehl A, Cascio D, Egea PF Protein Sci. 2015 Jun 30. doi: 10.1002/pro.2739. PMID:26130467[1]
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
See Also
References
- ↑ AhYoung AP, Koehl A, Cascio D, Egea PF. Structural mapping of the ClpB ATPases of Plasmodium falciparum: Targeting protein folding and secretion for antimalarial drug design. Protein Sci. 2015 Jun 30. doi: 10.1002/pro.2739. PMID:26130467 doi:http://dx.doi.org/10.1002/pro.2739
|
